Fourteen-Year Anti-TNF Therapy in Crohn’s Disease Patients: Clinical Characteristics and Predictive Factors

被引：0
|
作者：
Aisaku Osamura
Yasuo Suzuki
机构：
[1] Toho University,Department of Internal Medicine, Sakura Medical Center
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Crohn’s disease; Loss of response; Infliximab; Adalimumab; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：204 / 208
页数：4
相关论文
共 50 条
  • [31] SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN'S DISEASE
    Rezik, Mohamed
    Mattina, Deirdre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1042 - 1042
  • [32] Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease
    Desai, Alka A.
    Marks, Daniel J. B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 695 - 699
  • [33] Anti-TNF Treatment in Crohn's Disease: Toward Tailored Therapy?
    D'Haens, Geert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1140 - 1141
  • [34] Practical Application of Anti-TNF Therapy for Luminal Crohn's Disease
    Kamm, Michael A.
    Ng, Siew C.
    De Cruz, Peter
    Allen, Patrick
    Hanauer, Stephen B.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (11) : 2366 - 2391
  • [35] Anti-TNF antibody therapy in Crohn's disease: the risk of a switch
    Ricart, Elena
    Ordas, Ingrid
    Panes, Julian
    GUT, 2012, 61 (02) : 169 - 170
  • [36] Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease
    Hradsky, Ondrej
    Kazeka, Denis
    Copova, Ivana
    Lerchova, Tereza
    Mitrova, Katarina
    Pospisilova, Kristyna
    Sulovcova, Miroslava
    Zarubova, Kristyna
    Bronsky, Jiri
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (09) : 3001 - 3008
  • [37] Early anti-TNF/immunomodulator therapy is associated with better clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors
    Oh, E. H.
    Oh, K.
    Seo, H.
    Chang, K.
    Kim, G. -U.
    Song, E. M.
    Seo, M.
    Lee, H. -S.
    Kwon, E. J.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Kim, K. -J.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S324 - S324
  • [38] EARLY ANTI-TNF/IMMUNOMODULATOR THERAPY IS ASSOCIATED WITH BETTER CLINICAL OUTCOMES IN ASIAN PATIENTS WITH CROHN'S DISEASE WITH POOR PROGNOSTIC FACTORS
    Oh, Eun Hye
    Oh, Kyunghwan
    Seo, Hyungil
    Chang, Kiju
    Kim, Gwang-un
    Song, Eun Mi
    Seo, Myeongsook
    Lee, Ho-Su
    Kwon, Eun Ja
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Kim, Kyung-Jo
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    GASTROENTEROLOGY, 2017, 152 (05) : S26 - S27
  • [39] Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn’s disease
    Ondrej Hradsky
    Denis Kazeka
    Ivana Copova
    Tereza Lerchova
    Katarina Mitrova
    Kristyna Pospisilova
    Miroslava Sulovcova
    Kristyna Zarubova
    Jiri Bronsky
    European Journal of Pediatrics, 2021, 180 : 3001 - 3008
  • [40] Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease
    Chaparro, M.
    Aterido, A.
    Guerra, I.
    Iborra, M.
    Cabriada, J.
    Bujanda, L.
    Taxonera, C.
    Garcia-Sanchez, V.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Vera, I.
    Martin-Arranz, M.
    Hernandez-Breijo, B.
    Mesonero, F.
    Sempere, L.
    Gomollon, F.
    Hinojosa, J.
    Algaba, A.
    Beltran, B.
    Rodriguez Pescador, A.
    Banales, J.
    Olivares, D.
    Aguilar-Melero, P.
    Menchen, L.
    Ferreiro-Iglesias, R.
    Blazquez Gomez, I.
    Benitez Garcia, B.
    Guijarro, L.
    Marin, A. C.
    Bernardo, D.
    Marsal, S.
    Julia, A.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S530 - S531
12345